for the Period Ended 30 November 2024
| Balance sheet | |
| Additional notes | |
| Community Interest Report |
As at
| Notes | 2024 | 2023 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Current assets | |||
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Provision for liabilities: |
|
(
|
|
| Total net assets (liabilities): |
|
|
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 November 2024
Basis of measurement and preparation
for the Period Ended 30 November 2024
| 2024 | 2023 | |
|---|---|---|
| Average number of employees during the period |
|
|
The company is a professional association of pharmacists who are based in or have links to Southern Africa. The membership is comprised of individuals based mainly in Southern Africa and the UK, but also other parts of the world. The company provides a platform for discussion and sharing of knowledge related to healtheare issucs. The company activities have benefitted the community in the following ways;- membersshave ha benefited from continuing professional development (CPD) sessions that have been organised by the company.- members have been able to share knowledge on and discuss professional matters via the company's social media platforms.- members have been able to gain access to educational opportunities and invites to forums/conferences asaresult of the company's activities
The company's stakeholders are the membership. The company's executive is charged with the day to day running of the company. Members are asked for their input on what activities could be of benefit to them. This is done via surveys, question and answer sessions in meetings, and direct conversation.The interaction with membership has enabled the company to give members access to Continuing Professional Development sessions and support institutions/organisations identified by membership.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
31 August 2025
And signed on behalf of the board by:
Name: Thomas Thomik
Status: Director